Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)
Titel:
Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)
Auteur:
Conconi, A. Martinelli, G. Lopez-Guillermo, A. Zinzani, P.L. Ferreri, A.J.M. Rigacci, L. Devizzi, L. Vitolo, U. Luminari, S. Cavalli, F. Zucca, E.